Equity Research, Broker Reports, and media content on Oxford BioMedica plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Oxford BioMedica plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Oxford BioMedica plc

Company Profile

  • Personnel
  • John Dawson, CEO
  • Stuart Paynter, CFO

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Oxford BioMedica plc. We currently have 189 research reports from 9 professional analysts.

  • Open: 989p
  • Range Today: 955/990p
  • 52 Week: 357/1090p
  • Daily Volume: 146.5k
  • Daily Liquidity: (0.18%)
  • # Shares: 82.1m
  • Market Cap: £805.9m
  • Latest PE (hist):
  • Div Yield:
Date Source Announcement
04Jan21 14:09 RNS Block Listing Return
04Jan21 13:41 RNS Total Voting Rights
30Dec20 09:03 RNS OXB notes AZ vaccine has been authorised in the UK
01Dec20 12:17 RNS Director Dealings
01Dec20 09:02 RNS Total Voting Rights
23Nov20 08:47 RNS OXB notes AZD1222 met primary efficacy endpoint
23Nov20 07:00 RNS Non-Executive Director Appointment
  • Frequency of research reports


  • Research reports on

    Oxford BioMedica plc

  • Providers covering

    Oxford BioMedica plc